The mission of the Medical Scientist Training Program (MSTP) of the Albert Einstein College of Medicine is to train physician-scientists who will become future leaders in biomedical and clinical research. The MSTP strives to recruit a diverse group of outstanding students. It provides them with rigorous integrate medical and research training that prepares them for careers as physician-scientists. Through a flexible and continously evolving curriculum that includes 1) specialized MSTP courses and 2) integration of graduate and medical school curriculum in the first 2 years, the students are guided through a program that can be tailored to meet their individual needs and interests. The progam seeks to provide the trainees with a solid foundation for careers as independent physician-scientists and to facilitate their placement into outstanding postgraduate training programs to facilitate the next step in their career progression. The training program has 3 phases. In the first 2 years students take an integrated combination of medical, graduate and MSTP-specific courses to provide the didactic foundation for their reseach and clinical training. They perform research rotations to assist them in choosing their thesis research lab. In the program's 2nd phase, they perform independent, original research under their mentor's guidance. They publish their discoveries in high quality peer-reviewed papers, and prepare and defend a PhD thesis. Participation in an evening, MSTP-run, ambulatory outpatient clinic allows them to build their clinical skills during the PhD phase of the program. In the final phase, they complete their clinical training on the wards. We are developing a longitudinal learning experience to foster rigor and reproducibility in the research performed by MSTP students. The admissions process seeks to identify individuals with the intelligence, curiosity, creativity, resilience, perseverence and enthusiam for science that is essential for future success in a research career. Currently, 103 trainees are in the program, 37% are woman and 25% are members of underrepresented minorities. We plan to expand the program to a steady state size of ~120-130 trainees by increasing the size of our entering class to 16. Since its inception in 1964, as one of the first three NIH funded MD-PhD training programs, 425 trainees have graduated. 346 have completed postgraduate training and published over 18,000 papers, an average of 53 papers per graduate. 74% have jobs at academic medical centers, research institutes, NIH or pharmaceutical companies. By various measures, the program graduates have achieved outstanding success in their chosen careers. They have advanced biomedical research and academic medicine. Based on the quality of our past accomplishments and the new developments in biomedical research, we propose to evolve the program, to further integrate graduate and medical training, and increase opportunities for involvement in clinical and translational research in order to prepare a future generation of physician-scientists who will be at the leading edge of biomedical research with the ultimate goal of improving human health and reducing the burden of disease.

Public Health Relevance

Physician-scientists perform a critical role at the interface between basic biomedical research and clinical medicine. This program will train a diverse group of outstanding students and prepare them to enter the biomedical research workforce as physician-scientists who will perform basic, translational, and clinical research. This research will lead to new treatments to prevent or cure disease and improve the health of all Americans.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Institutional National Research Service Award (T32)
Project #
6T32GM007288-46
Application #
9862114
Study Section
NIGMS Initial Review Group (TWD)
Program Officer
Maas, Stefan
Project Start
1975-07-01
Project End
2023-06-30
Budget Start
2019-01-01
Budget End
2019-06-30
Support Year
46
Fiscal Year
2018
Total Cost
Indirect Cost
Name
Albert Einstein College of Medicine
Department
Type
DUNS #
081266487
City
Bronx
State
NY
Country
United States
Zip Code
10461
Gelb, Sivan; Stock, Ariel D; Anzi, Shira et al. (2018) Mechanisms of neuropsychiatric lupus: The relative roles of the blood-cerebrospinal fluid barrier versus blood-brain barrier. J Autoimmun 91:34-44
Mocholi, Enric; Dowling, Samuel D; Botbol, Yair et al. (2018) Autophagy Is a Tolerance-Avoidance Mechanism that Modulates TCR-Mediated Signaling and Cell Metabolism to Prevent Induction of T Cell Anergy. Cell Rep 24:1136-1150
Kratschmer, Christina; Levy, Matthew (2018) Targeted Delivery of Auristatin-Modified Toxins to Pancreatic Cancer Using Aptamers. Mol Ther Nucleic Acids 10:227-236
Biswas, Jeetayu; Liu, Yang; Singer, Robert H et al. (2018) Fluorescence Imaging Methods to Investigate Translation in Single Cells. Cold Spring Harb Perspect Biol :
Lázaro-Peña, María I; Díaz-Balzac, Carlos A; Bülow, Hannes E et al. (2018) Synaptogenesis Is Modulated by Heparan Sulfate in Caenorhabditis elegans. Genetics 209:195-208
Zhang, Yidan; Zvi, Yoav S; Batko, Brian et al. (2018) Down-regulation of Skp2 expression inhibits invasion and lung metastasis in osteosarcoma. Sci Rep 8:14294
Kaufman, Odelya H; Lee, KathyAnn; Martin, Manon et al. (2018) rbpms2 functions in Balbiani body architecture and ovary fate. PLoS Genet 14:e1007489
Cabrera, Ramon M; Mao, Serena P H; Surve, Chinmay R et al. (2018) A novel neuregulin - jagged1 paracrine loop in breast cancer transendothelial migration. Breast Cancer Res 20:24
Chalmers, Samantha A; Wen, Jing; Doerner, Jessica et al. (2018) Highly selective inhibition of Bruton's tyrosine kinase attenuates skin and brain disease in murine lupus. Arthritis Res Ther 20:10
Mike, Elise V; Makinde, Hadijat M; Der, Evan et al. (2018) Neuropsychiatric Systemic Lupus Erythematosus Is Dependent on Sphingosine-1-Phosphate Signaling. Front Immunol 9:2189

Showing the most recent 10 out of 721 publications